Skip to main content

Table 3 Literature scoping results

From: Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries

Priority policy issue No. of articles Assessing effect Methods
SRain LMIC (Total # SR) Quantitative Qualitative Mixed Other
1. Medicine selection and use        
Generic medicines 48 6 1 (1) 8 23 13 3
Clinical practice guidelines, Standard Treatment Guidelines, National Essential Medicines Lists 49 12 4 (4) 8 17 17 3
Health seeking behaviour of patients, households and communities 33 2 1 (3) 2 14 11 3
Overuse of medicines 34 4 2 (2) 11 12 7 2
Financial and non-financial incentives for providers 15 6 1 (4) 0 5 4 2
2. Sustainable financing and affordable prices        
Medicine and health financing arrangements 27 12 1 (4) 10 3 10 0
Resource allocation for health and medicines 3 1 0 (0) 1 00 1 1
Medicine pricing 41 12 0 (3) 19 0 9 10
3. Leadership and governance        
Cross-cutting policies above the health sector affecting health and medicine access 12 1 1 (1) 0 1 3 7
Governance over the private sector 28 4 1 (2) 4 14 2 6
Donors agenda, funding type and funding mechanisms 14 10 0 (0) 4   3 3
4. Availability of medicines        
Procurement, supply and stock management 12 2 0 (0) 5 4 3 0
Medicine availability in the public sector 29 5 1 (2) 6 4 14 3
Geographical accessibility 16 8 1 (1) 5 4 4 2
5. Human resources for health        
Deployment/shortage and training of human resources for health 3 2 0 (0) 0 1 2 0
6. Quality of medicines and quality assurance systems        
Counterfeit medicines 9 2 3 (3) 1 1 2 2
Substandard medicines 34 9 1 (1) 8 12 5 8
7. Medicine information and information systems        
Monitoring and evaluation systems on rational use, price and quality 35 4 1 (1) 4 11 8 11
  1. aSystematic reviews.